Influenza Vaccine Efficacy in Tropical and Developing Countries

The summary for the Influenza Vaccine Efficacy in Tropical and Developing Countries Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Influenza Vaccine Efficacy in Tropical and Developing Countries
	CFDA Number:	93.283
	CFDA Description:	Centers for Disease Control and Prevention_Investigations and Technical Assistance
	Federal Agency Name:	Centers for Disease Control and Prevention
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-IP-11-013
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	Dec 30, 2010
	Creation Date:	Dec 30, 2010
	Original Closing Date for Applications:	Mar 14, 2011 On-time submission requires that electronic applications be error-free and made available to CDC for processing from eRA Commons on or before the deadline date. Applications must be submitted to and validated successfully by Grants.gov/eRA Commons no later than 5:00 PM Eastern Time. Note:.HHS/CDC grant submission procedures do not provide a period of time beyond the application due date to correct any error or warning notices of noncompliance with application instructions that are identified by Grants.gov or eRA systems (i.e., error correction window).
	Current Closing Date for Applications:	Mar 14, 2011 On-time submission requires that electronic applications be error-free and made available to CDC for processing from eRA Commons on or before the deadline date. Applications must be submitted to and validated successfully by Grants.gov/eRA Commons no later than 5:00 PM Eastern Time. Note:.HHS/CDC grant submission procedures do not provide a period of time beyond the application due date to correct any error or warning notices of noncompliance with application instructions that are identified by Grants.gov or eRA systems (i.e., error correction window).
	Archive Date:	Apr 13, 2011
	Expected Number of Awards:	2
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	$1,250,000
	Federal Grant Award Floor:	$0
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Eligibility is limited to PATH and the University of Alabama, Birmingham who have been funded under RFA IP08-002 since 2008 because
Grant Description: A limited number of studies have suggested that influenza vaccination of select groups in a population provides protection to both vaccinated and unvaccinated persons, including those who respond poorly to vaccination, by decreasing transmission within a community to susceptible persons. Few studies have been conducted to assess the indirect effects of influenza vaccination, either at the household or the community level. Apart from an observational study that was conducted during the 1968 pandemic, few data are available to evaluate the effects of influenza vaccination on rates of illness among non-vaccinated persons in a community. Furthermore, no information is available on effectiveness of vaccines in populations from tropical, developing countries, where influenza vaccine use remains limited. In these countries, differences in social interactions, population density, household composition, and school attendance could alter the transmission characteristics of influenza compared to those in the United States and other developed countries in temperate climates. As the next influenza pandemic could arise in a tropical, developing country, such information is critical to effective planning and preparedness, but will also add to the general understanding of the dynamic interplay between influenza transmission, social structure, and population immunity. Information obtained from such studies will also provide important data on strategies for the use of influenza vaccine during a pandemic, when the supply of vaccine will likely be limited. Results from these studies will also provide important information on the epidemiology and disease burden of influenza in tropical regions, and on the potential benefits of seasonal vaccination programs in developing countries.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: Centers for Disease Control and Prevention (CDC) Procurement and Grants Office (PGO) Technical Information and Management Section (TIMS) Phone 770-488-2700

General Email [pgotim@cdc.gov]
Similar Government Grants: • Promoting CDC's Cancer Surveillance Data through Workforce Development and Education; • Development and Implementation of Programs to Enhance Epilepsy Public Awareness, Knowledge and Partn...; • Enhanced Data Collection of Central Nervous System Malignant and Non-Malignant Tumors; • Enhancing Cancer Registries for Early Case Capture of Pediatric and Young Adult Cancer Cases; • Innovative Social Media Strategies to Reach Open to Smoking Youth; • Postdoctoral Fellowship Training Program in Infectious Diseases; • A Cooperative Agreement to Improve the Interaction Between Public Health Academicians and Public Hea...; • A Cooperative Agreement to Strengthen Collaboration Between the Disciplines of Academic Medicine and...; • A Cooperative Agreement to Advance the Practice of Preventive Medicine; • Academic Partners Public Health Training Grant